🎟️ Join us at The Psychedelic Healthcare Forum in NYC
In this video, Psychedelic Alpha’s Josh Hardman reviews various steps that need to be taken to take psychedelics from potential FDA approvals to provider and patient access.
For deeper dive analysis and coverage of all of these dynamics over the coming weeks, months, and years, join Pα+ today.
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.
By signing up, you agree to our privacy policy. You can unsubscribe at any time.
Aside from group pricing, we also offer bespoke reports and regular briefings. Get in touch to discuss.